Find a Clinical Trial

Search by Condition, Study Number, or Keyword

Enter City, State, or Zip Code

Researching Blood Cancer

Blood cancers form in the bone marrow where blood is made, or in the lymphatic system, which protects us from infections.

Blood Cancer Clinical Trials

We are currently investigating experimental medications for Multiple Myeloma, Lymphoma and Leukemia.

Multiple Myeloma is a type of blood cancer which forms in plasma cells.
Lymphomas are blood cancers that target the immune system.
Leukemia is a cancer of the blood and bone marrow caused by too many white blood cells, leukemia takes on several forms and can occur in both children and adults.

Blood Cancer Trials

CA057-001

Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company

View Trial Details

CA056-025

Recruiting

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

View Trial Details

CA073-1022

Recruiting

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company

View Trial Details

CA073-1020

Recruiting

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company

View Trial Details

CA056-015

Recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

View Trial Details

CA057-008

Recruiting

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

View Trial Details

ACE-536-B-THAL-004

Recruiting

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company

View Trial Details

CA224-069

Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

View Trial Details

IM048-022

Recruiting

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

View Trial Details

CA088-1007

Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

View Trial Details

CA073-1003

Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)

Celgene Corporation, a wholly owned subsidiary of Bristol-Myers Squibb Company

View Trial Details

CA204-008

Recruiting

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

View Trial Details

JCAR017-FOL-001

Recruiting

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

Juno Therapeutics and Celgene are wholly owned subsidiaries of Bristol-Myers Squibb Company

View Trial Details

Answer a few questions about your health to find out which trials might be a good fit for your situation.

Pre-Screen Now

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Email Us

Have questions?

Email Us

Researching Blood Cancer

Blood Cancer Clinical Trials

Blood Cancer Clinical Trials

Blood Cancer Trials

Let us help you find a trial you might qualify for

About

About

NEED HELP?

NEED HELP?